𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells

✍ Scribed by Jin Won Yang; Mi Ra Kim; Hyung Gyoon Kim; Sang Kyum Kim; Hye Gwang Jeong; Keon Wook Kang

Book ID
107641764
Publisher
Springer
Year
2008
Tongue
English
Weight
371 KB
Volume
31
Category
Article
ISSN
0253-6269

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Lack of modulation of MDR1 gene expressi
Lack of modulation of MDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant mcf-7 breast cancer cells
✍ Amadeo M. Parissenti; Brian R. Gannon; David J. Villeneuve; Angela F. Kirwan-rhu πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 172 KB πŸ‘ 2 views

The drug transporter P-glycoprotein (P-gp) appears to play an important role in the ability of tumor cells to evade killing by chemotherapeutic agents. Using pharmacological inhibitors of cAMP-dependent protein kinase (PKA), it has been suggested that, similar to rodent model systems, the human P-gp

Expression of a phosphorylated p130Cas s
Expression of a phosphorylated p130Cas substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells
✍ Shefali Soni; Bor-Tyh Lin; Avery August; Robert I. Nicholson; Kathrin H. Kirsch πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 445 KB

## Abstract Elevated expression of p130^Cas^/BCAR1 (breast cancer anti estrogen resistance 1) in human breast tumors is a marker of poor prognosis and poor overall survival. Specifically, p130^Cas^ signaling has been associated with antiestrogen resistance, for which the mechanism is currently unkn